Bristol-Myers Squibb (BMS) has named former chief operating officer Giovanni Caforio as the company’s new CEO.
Bristol-Myers Squibb (BMS) has named former chief operating officer Giovanni Caforio as the company’s new CEO, effective May 5. He will replace Lamberto Andreotti, who will become executive chairman of the board. Caforio has led transformational deals in BMS’s U.S. and global oncology departments. He has also served at the company as chief commercial officer and chief operating officer and has been a member of its senior management team since 2011.
Can Data and AI Deliver Whole-Person Health?
July 9th 2024Executives in the life sciences and medical device industries see promise in artificial intelligence (AI) and medical technologies, but must also navigate the changing healthcare ecosystem, varied stakeholder needs, and the impact of AI on market access and commercialization strategies.